-
NEWS
Breaking News! Tongling Bionics Forges Strategic Partnership with Transvascular Implant Instrument Research Institute
2024-12-19
On the morning of December 18, the Transvascular Implant Instrument Research Institute (hereinafter referred to as the "Institute") was inaugurated in Binjiang District, Hangzhou, affiliated with the Second Affiliated Zhejiang University School of Medicine. This milestone marks the establishment of China's first innovation platform dedicated to high-end transvascular implantable Instruments.
The ceremony was attended by distinguished guests, including:
Wang Jian'an, Academician of the Chinese Academy of Sciences, and Party Secretary of the hospital，President of the Institute;
Zheng Di, Deputy Party Secretary and Director of the Management Committee of Hangzhou High-Tech Zone (Binjiang District), and District Mayor;
Ding Changyu, Standing Committee Member of the Hangzhou High-Tech Zone (Binjiang District) Party Committee and Party Secretary of Zero-Magnetic Science Valley (Smart New World);
Wang Lisheng, Deputy Director of Hangzhou High-Tech Zone Management Committee;
Weng Yu, Director of the Science and Technology Development Department at Zhejiang University's Research Institute;
Ji Jian, Executive Vice President of the Institute;
Xie Qilian, Chairman of Anhui Tongling Bionics Technology Ltd.
During the event, Xie and Ji signed a strategic agreement to establish a joint laboratory, initiating a multi-million-yuan collaboration to advance innovation in the field.
Supported by Zhejiang University, the hospital, and the Binjiang District Government, the Institute is led by Academician Wang Jian'an. It integrates medicine, engineering, and interdisciplinary research to address critical challenges in transvascular implantable instruments. The Institute aims to break through next-generation transvascular implant/intervention technologies, build a world-class R&D and clinical center, and cultivate top-tier talent in the field.
Tongling Bionics is committed to becoming a comprehensive heart failure management solutions provider across the full care continuum. As China's pioneer in developing percutaneous ventricular assist devices (pVADs), Tongling Bionics has amassed extensive expertise and technological achievements in transvascular interventional devices. Currently, its products are undergoing multicenter clinical trials across China, with their performance receiving high acclaim from medical professionals.
"This partnership will leverage the Institute's cutting-edge platform to deepen technical exchanges, accelerate R&D, and elevate domestic medical device innovation—ultimately safeguarding public health." Xie emphasized.
Latest News
Anhui Tongling Bionics Technology Ltd.
WeChat official account
Anhui Tongling Bionics Technology Ltd.
Copyright © 2025 Anhui Tongling Bionics Technology Ltd.
Copyright © 2025 Anhui Tongling Bionics Technology Ltd.